Skandinaviska Enskilda Banken (SEB)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-60,514
| Closed | -$1.89M | – | 784 |
|
|
2023
Q4 | $1.89M | Hold |
60,514
| – | – | 0.01% | 595 |
|
|
2023
Q3 | $1.26M | Hold |
60,514
| – | – | 0.01% | 642 |
|
|
2023
Q2 | $1.45M | Hold |
60,514
| – | – | 0.01% | 630 |
|
|
2023
Q1 | $1.14M | Sell |
60,514
-2,956
| -5% | -$55.6K | 0.01% | 676 |
|
|
2022
Q4 | $1.01M | Sell |
63,470
-3,677
| -5% | -$58.5K | 0.01% | 665 |
|
|
2022
Q3 | $1.1M | Hold |
67,147
| – | – | 0.01% | 659 |
|
|
2022
Q2 | $946K | Hold |
67,147
| – | – | 0.01% | 717 |
|
|
2022
Q1 | $1.63M | Buy |
67,147
+19,690
| +41% | +$477K | 0.01% | 662 |
|
|
2021
Q4 | $1.12M | Sell |
47,457
-43,300
| -48% | -$1.02M | 0.01% | 754 |
|
|
2021
Q3 | $1.51M | Sell |
90,757
-67,600
| -43% | -$1.12M | 0.01% | 714 |
|
|
2021
Q2 | $3.86M | Buy |
158,357
+121,835
| +334% | +$2.97M | 0.02% | 478 |
|
|
2021
Q1 | $942K | Buy |
+36,522
| New | +$942K | 0.01% | 842 |
|
|
2020
Q3 | – | Sell |
-19,600
| Closed | -$950K | – | 1022 |
|
|
2020
Q2 | $950K | Buy |
+19,600
| New | +$950K | 0.01% | 730 |
|